Tag: Molecularly targeted therapy

Correction: Evolution of Claudin18.2 Therapies in Gastroesophageal Cancers

July 18, 2026

Correction: Evolution of Claudin18.2 Therapies in Gastroesophageal Cancers

Zodasiran Lowers Triglycerides and LDL Cholesterol in Phase 1 Trial

April 8, 2026

Zodasiran Lowers Triglycerides and LDL Cholesterol in Phase 1 Trial

Web Analytics